Jatinder Harchowal

4 June 2019
BMA House, London

Industry expert

 Jatinder Harchowal

Jatinder Harchowal

, , The Royal Marsden NHS Foundation Trust , Chief Pharmacist

Jatinder has been a hospital pharmacist for over 25 years. He is currently Chief Pharmacist and a Clinical Director in the Royal Marsden Hospital (RMH), a world leading cancer hospital, leading a team of 140 staff to ensure patients receive the most up to date medicines in the safest way. Jatinder is also the medicines lead for the RM Partners West London Cancer Alliance - a programme designed to test new and innovative pathways to improve the earlier diagnosis of patients with cancer and recently led on a programme to introduce biosimilar Rituximab safely and consistently in oncology. 

Jatinder has been a Chief Pharmacist for over 14 years in various hospitals including Brighton and Ealing. He also has been the pharmacy advisor to the Clinical Advisory Group for the Healthcare for London programme, advising on the structure of healthcare services for the capital. Jatinder has previously worked in a number of different pharmacist roles in various hospitals across London, including Barts, King’s College and Charing Cross Hospitals.  

He qualified in 1991 with a Bachelor in Pharmacy Degree and became a member of the Royal Pharmaceutical Society. Jatinder obtained a Diploma in Clinical Pharmacy in 1993, an MSc in Clinical Pharmacy Practice in 1996 from London and completed Diploma in Management Studies in 2000 with the Kingston University.  Jatinder is a current Health Foundation fellow and has recently completed the Health Foundation’s Masters in Leadership and Quality Improvement programme (Generation Q) and has a passion for improving national health services for patients.


By continuing to use the site you agree to our cookies policy. Accept